These compounds may interact with:

Mitogen-activated protein kinase 10

Potentially involved in: intellectual disability; epilepsy; carcinoma; brain ischemia; neurodegenerative disease; aggressive behavior; mental retardation; myoclonus; personality disorders; encephalopathies; mental deterioration; lennox-gastaut syndrome; epileptic drop attack; low intelligence; hyperactive behavior; physical aggression; tonic - clonic seizures; atypical absence seizure; autistic behavior; mental deficiency

Disease data sourced from Pharos.